Retour
Fourchette du Jour
13,57 €
14,84 €
Fourchette 52 Semaines
13,57 €
25,67 €
Volume
5 220 745
Moyenne 50J / 200J
16,39 €
/
17,09 €
Clôture Précédente
14,32 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 22,0 | 0,4 |
| P/B | 6,8 | 2,9 |
| ROE % | 35,6 | 3,7 |
| Net Margin % | 28,8 | 3,8 |
| Rev Growth 5Y % | 58,5 | 10,0 |
| D/E | 0,2 | 0,2 |
Points Clés
Revenue grew 58,45% annually over 5 years — strong growth
Earnings declined -25,67% over the past year
ROE of 35,56% indicates high profitability
Net margin of 28,80% shows strong profitability
Debt/Equity of 0,17 — conservative balance sheet
Generating 27,82M in free cash flow
Croissance
Revenue Growth (5Y)
58,45%
Revenue (1Y)19,63%
Earnings (1Y)-25,67%
FCF Growth (3Y)169,91%
Qualité
Return on Equity
35,56%
ROIC25,77%
Net Margin28,80%
Op. Margin37,53%
Sécurité
Debt / Equity
0,17
Current Ratio6,71
Interest Coverage26,93
Valorisation
P/E Ratio
22,03
P/B Ratio6,78
EV/EBITDA16,87
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19,63% | Revenue Growth (3Y) | 40,56% |
| Earnings Growth (1Y) | -25,67% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 58,45% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 510,17M | Net Income (TTM) | 146,93M |
| ROE | 35,56% | ROA | 23,54% |
| Gross Margin | 57,39% | Operating Margin | 37,53% |
| Net Margin | 28,80% | Free Cash Flow (TTM) | 27,82M |
| ROIC | 25,77% | FCF Growth (3Y) | 169,91% |
| Safety | |||
| Debt / Equity | 0,17 | Current Ratio | 6,71 |
| Interest Coverage | 26,93 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 22,03 | P/B Ratio | 6,78 |
| P/S Ratio | 6,34 | PEG Ratio | -1,09 |
| EV/EBITDA | 16,87 | Dividend Yield | 0,00% |
| Market Cap | 3,24B | Enterprise Value | 3,23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 510,17M | 426,45M | 258,22M | 154,08M | 80,94M |
| Net Income | 146,93M | 197,67M | -28,24M | -65,90M | -71,65M |
| EPS (Diluted) | 0,60 | 0,81 | -0,13 | -0,43 | -0,61 |
| Gross Profit | 292,77M | 219,55M | 88,94M | 35,27M | 1,17M |
| Operating Income | 191,44M | 138,98M | 21,63M | -39,37M | -58,37M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 624,24M | 488,68M | 329,18M | 348,46M | 276,25M |
| Total Liabilities | 146,92M | 139,66M | 193,98M | 196,49M | 135,08M |
| Shareholders' Equity | 477,32M | 349,02M | 135,21M | 151,97M | 141,17M |
| Total Debt | 79,89M | 82,12M | 141,42M | 154,44M | 102,92M |
| Cash & Equivalents | 87,63M | 103,15M | 51,35M | 86,52M | 51,09M |
| Current Assets | 466,51M | 331,41M | 257,01M | 270,40M | 208,73M |
| Current Liabilities | 69,54M | 55,54M | 49,81M | 39,27M | 30,38M |